Back to Search
FREDERICK AHMANN, MD
MD
Hematology & Oncology Physician
NPI: 1700857166Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
10449(AZ)
Research & Publications (7)
MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure.
PMID 18931824·Invest New Drugs·2009
3-trial
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.
PMID 17308272·J Clin Oncol·2007
3-trial
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
PMID 17308271·J Clin Oncol·2007
4-observational
Coccidioidomycosis of the prostate: a determination of incidence, report of 4 cases, and treatment recommendations.
PMID 15936822·J Infect·2006
5-case
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
PMID 14501381·Anticancer Drugs·2003
3-trial
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
PMID 14501380·Anticancer Drugs·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 3838 N CAMPBELL AVE
TUCSON, AZ 85719 - Phone
- (520) 694-2873
Quick Facts
- NPI
- 1700857166
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile